Enforcement against illicit alternative nicotine products on the US market has come to the fore since the Food and Drug Administration (FDA)’s budget for the first time includes a minimum floor for it.
But there appears to be a disconnect in how leadership at the FDA and the wider Department of Health and Human Services (HHS) discuss vaping.
For the first time ever, a minimum – of $200m – has been specified to be spent on enforcement activities specifically against illicit vaping products in the US market for the 2026 fiscal year.
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.
Our Key Benefits
The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation
Want the full analysis? Let's talk
We share insights with professionals we’re in contact with. Let us know a bit about your interest.